Once daily dosing with neoral utilizing C2 monitoring in de novo liver transplant patients.

被引：0
|
作者：
Levy, GA [1 ]
Lilly, LB [1 ]
Girgrah, NT [1 ]
Cattral, MS [1 ]
Greig, PD [1 ]
Smith, R [1 ]
Grant, DR [1 ]
机构：
[1] Toronto Gen Hosp, Toronto, ON, Canada
来源：
LIVER TRANSPLANTATION | 2004年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
294
引用
收藏
页码：C74 / C74
页数：1
相关论文
共 50 条
  • [21] C2 therapeutic drug monitoring of cyclosporine is a safe and feasible method in de novo heart transplant patients
    Puehler, T.
    Goepel, L.
    Von Tschirschnitz, M.
    Struckmeyer, U.
    Ernst, M.
    Ladenburger, S.
    Schmid, C.
    Cremer, J.
    Hirt, S. W.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (10) : 3329 - 3333
  • [22] Population Pharmacokinetics and Pharmacogenetics of Once Daily Tacrolimus Formulation in Liver Transplant Patients.
    Moes, Dirk J. A. R.
    van der Bent, Sebastiaan A. S.
    Swen, Jesse J.
    Straaten, Tahar
    Verspaget, Hein W.
    Guchelaar, Henk-Jan
    den Hartigh, Jan
    van Hoek, Bart
    LIVER TRANSPLANTATION, 2014, 20 : S106 - S107
  • [23] Optimization of cyclosporine exposure utilizing C2 level monitoring in de novo renal transplant recipients:: The Toronto general hospital experience
    Maham, N
    Cardella, C
    Cattran, D
    Fenton, S
    O'Grady, C
    Hamill, J
    Smith, R
    Cole, E
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3098 - 3099
  • [24] Observational study on the conversion from C0 to C2 monitoring of cyclosporine (Neoral) in stable liver transplant recipients
    Situmorang, G
    Jones, R
    Berry, R
    Fink, M
    Wang, BZ
    Gow, P
    Angus, P
    IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (02): : A22 - A22
  • [25] Efficacy of C0 and C2 monitoring in adult liver transplant recipients treated with neoral, mycophenolate mofetil, and steroids
    Treckmann, J.
    Paul, A.
    Oezcelik, A.
    Saner, F.
    Malago, M.
    Nadalin, S.
    Lang, H.
    Malamutman, E.
    Gerken, G.
    Broeisch, C. E.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (10) : 3234 - 3236
  • [26] C2 monitoring using 4-hour intravenous infusions of cyclosporine in de novo liver transplant recipents.
    Lück, R
    Böger, J
    Kuse, E
    Klempnauer, J
    Nashan, B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 361 - 361
  • [27] Outcome of neoral C2 level monitoring in Asian kidney transplant recipient.
    Praditpornsilpa, K
    Avihingsanon, Y
    Kansanabuch, T
    Eiam-Ong, S
    Chusil, S
    Tungsanga, K
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 236 - 236
  • [28] Use of a once daily modified release tacrolimus regimen in de novo liver transplant recipients.
    Undre, NA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 374 - 374
  • [29] Efficacy of C2 monitoring of cyclosporine Neoral in adult liver transplantation:: A comparative study
    Santoyo, J
    Suarez, MA
    Perez-Daga, JA
    Aguilar, JLF
    Rodrigo, J
    Jiménez, M
    Bondia, JA
    De la Fuente, A
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3096 - 3097
  • [30] Impact of cyclosporine C2 monitoring on renal function in de novo heart transplant patients: 10-year experience
    Cantarovich, M.
    Giannetti, N.
    Edwardes, M. deB.
    Fontaine, G.
    Chartier, R.
    Cyr, F.
    Cecere, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S136 - S136
12345